Results 121 to 130 of about 14,058 (258)
Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics [PDF]
, 2012 Introduction: In order to assess the significance of drug levels measured in intensive care medicine, clinical and forensic toxicology, as well as for therapeutic drug monitoring, it is essential that a comprehensive collection of data is readily ...
Andresen, Hilke +3 more
core +1 more source
Vascular Health and Risk Management, 2008 André C Schmidt1, Burkhard Flick1, Elke Jahn2, Peter Bramlage31Charité – Universitätsmedizin Berlin, Institute for Clinical Pharmacology and Toxikology, Berlin, Germany; 2Berlin-Chemie AG, Clinical Research and Medical ...
André C Schmidt +3 more
doaj
Estudio de utilización de medicamentos betabloqueantes en la provincia de Huelva [PDF]
, 2003 Métodos: El presente trabajo analiza el consumo de me dicamentos {>-bloqueantes, en Dosis Diarias Definida por cada 1.000 habitantes y día en cada uno de los siete Distritos Sani tarios en que se encuentra dividida la provincia de Huelva, du ...
Bravo Díaz, Luis +3 more
core
Rhabdomyolysis in a patient taking nebivolol
Kidney Research and Clinical Practice, 2016 β Blockers such as propranolol and labetalol are known to induce toxic myopathy because of their partial β2 adrenoceptor agonistic effect. Nebivolol has the highest β1 receptor affinity among β blockers, and it has never been reported to induce ...
Ye Jin Kim +7 more
doaj +1 more source
P-225: Effective blood-pressure control with valsartan/HCTZ combination therapy in patients with moderate to severe systolic hypertension: The valor trial [PDF]
, 2017 Increasing evidence shows that combination therapy with at least two antihypertensive agents is needed to achieve appropriate blood-pressure (BP) control in a large part of the hypertensive population.
Assouline, Linda +4 more
core
КардиоСоматика, 2013 Objective: to evaluate the antihypertensive efficacy and effect of nebivolol and valsartan on metabolic parameters and erective function in patients with hypertension, metabolic syndrome, and erectile dysfunction. Subjects and methods.
S. V Nedogoda +5 more
doaj
Pulmonary effects of nebivolol
Therapeutic Advances in Cardiovascular Disease, 2009 The pharmacological control of arterial hypertension is a very frequent issue in clinical practice and some critical aspects can arise in particular circumstances and with particular molecules. In the case of hypertensive subjects with respiratory comorbidities, when first introduced, these β-adrenergic receptor antagonists were described as affecting
openaire +2 more sources
Кардиоваскулярная терапия и профилактика, 2006 Aim. To assess nebivolol clinical effects on intravascular platelet activity in patients with arterial hypertension (AH) and metabolic syndrome (MS). Material and methods. In total, 21 patients were administered nebivolol (5 mg/d) for one month. Dynamics
I. N. Medvedev
doaj
Al-Mustansiriyah Journal of Pharmaceutical SciencesLiver injury can arise post-exposure to drugs or their metabolites, as well as herbal and dietary supplements. Tamoxifen is a frequently used drug in breast cancer treatment.
Noor Ahmed Hammadi +2 more
doaj +1 more source